Company news
Twist Bioscience Corporation news in 2022
Twist Bioscience Corporation's news releases, calls and decks from 2022, newest first.
Twist Bioscience’s Comprehensive DNA Synthesis Capabilities Expanded as Industry-Leading Enzymatic Synthesis Process Unveiled at Annual J.P. Morgan Healthcare Conference
January 9, 2022
Twist Bioscience Creates Custom Whole Exome Target Enrichment Panel for Canine Genomic Research
January 5, 2022
Revelar Biotherapeutics and Twist Bioscience Announce RBT-0813 Neutralizes SARS-CoV-2 Omicron (B.1.1.529/BA.1) and Delta (B.1.617.2) Variants
January 4, 2022
Twist Bioscience to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 3, 2022
Calls in 2022
Decks in 2022
- Technical Presentation (June 2022)
Technical · 24 slides · Jun 1, 2022